Evidence map›Paper›PMID 36305115›Full record

ArticleZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics2022

[Risk factors for acute kidney injury after hematopoietic stem cell transplantation in children: a retrospective study].

Jian Liu, Zhi-Wei Chen, Ying-Jie Wang, Yu-Miao Mai, Hui-Hui Hu, Bing Ren, Ying-Chao Wang, Yu-Feng Liu

Abstract readEnglish Abstract
In one paragraph

Article in Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jian LiuDepartment of Pediatrics, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Zhi-Wei ChenDepartment of Pediatrics, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Ying-Jie WangDepartment of Pediatrics, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Yu-Miao MaiDepartment of Pediatrics, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Hui-Hui HuDepartment of Pediatrics, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Bing RenDepartment of Pediatrics, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Ying-Chao WangDepartment of Pediatrics, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Yu-Feng LiuDepartment of Pediatrics, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo investigate the risk factors for acute kidney injury (AKI) after hematopoietic stem cell transplantation (HSCT) in children.

methodsA retrospective analysis was performed on the medical data of 111 children who underwent HSCT from January 2018 to January 2020. A multivariate logistic regression analysis was used to identify the risk factors for AKI. The Kaplan-Meier survival analysis was used to compare the prognosis in children with different grades of AKI.

resultsGraft-versus-host disease (grade Ⅱ-Ⅳ) (

conclusionsChildren with stage Ⅲ AKI after HSCT have a higher mortality rate. Graft-versus-host disease, hepatic veno-occlusive disease, and thrombotic microangiopathy are closely associated with the development of AKI after HSCT.

Indexed as

Acute Kidney InjuryGraft vs Host DiseaseHematopoietic Stem Cell TransplantationThrombotic MicroangiopathiesChildHumansRetrospective StudiesRisk FactorsAcute kidney injuryChildHematopoietic stem cell transplantationRisk factor

Identifiers

PMID36305115
PMCPMC9627998

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.